Literature DB >> 27908995

Complete Genome Sequence of Bacteroides ovatus V975.

Udo Wegmann1, Alexander Goesmann2, Simon R Carding3,4.   

Abstract

The complete genome sequence of Bacteroides ovatus V975 was determined. The genome consists of a single circular chromosome of 6,475,296 bp containing five rRNA operons, 68 tRNA genes, and 4,959 coding genes.
Copyright © 2016 Wegmann et al.

Entities:  

Year:  2016        PMID: 27908995      PMCID: PMC5137409          DOI: 10.1128/genomeA.01335-16

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

The human gastrointestinal tract hosts a plethora of resident microorganisms with bacterial cell densities in the colon reaching 1011 cells per g of content (1). Although an individual’s microbiota is unique and variable, a dominant phylogenetic core (2) consisting of members of the phyla Firmicutes and Bacteroidetes constitutes up to 90% of the colonic microbiota in all human populations (3, 4). Among the Bacteroidetes, representatives of the genus Bacteroides are among the most abundant bacterial species of the human colonic microbiota, of which Bacteroides ovatus, a Gram-negative, rod-shaped, non-spore-forming, and anaerobic bacterium, exists in more than 90% of individuals (5). As a member of the Bacteroidetes phylum, Bacteroides spp. diverged from the common line of eubacterial descent before the major eubacterial groups and are distinct from the other major Gram-negative phylum, the Proteobacteria (6). Their membranes contain sphingolipids (7), and the structure of their promoters (8) and ribosomal binding sites (9) is distinct from that of proteobacteria. Recent advances in the generation of genetic tools for Bacteroides, their prevalence among human populations, and the fact that these organisms are among the most stable components of the human gut microbiota (10) have led to the proposed use of genetically modified B. ovatus as a vehicle for the delivery of therapeutic agents in humans (11). This requires the complete genome sequence of the bacterium to facilitate its genetic manipulation and second, to evaluate its suitability with regard to biological and clinical safety. Hence, we undertook sequencing of the genome of B. ovatus V975. The complete genome sequence was determined using the Genome Sequencer FLX 454 system. The initial draft assembly provided by MWG-Biotech (Ebersberg, Germany) was based on a total of 488,596 pyrosequencing reads, with an average read length of 278 nucleotides (nt), and included 146,170 reads which had been generated following the long paired-end tag protocol. After Newbler assembly and contig ordering based on paired-end reads, the 6,489,366-Mbp draft assembly consisted of 44 contigs, which were distributed across 33 scaffolds, and the average per-base coverage was 23-fold. Standard PCR, followed by primer walk sequencing on the resulting products, was used to close the gaps located in scaffolds. Multiplex PCR was employed to identify adjoining contigs and respective primer pairs for which no linkage had been established previously, and upon reamplification under standard conditions, the resulting products were analyzed by primer walk sequencing. The sequence assembly was carried out with the Staden package (12), and the integrity of the assembly was confirmed by pulsed-field gel electrophoresis of restricted agarose embedded DNA in a CHEF-DR II electrophoresis system (Bio-Rad Laboratories, Hercules, CA), according to the manufacturer’s instructions. The finished B. ovatus sequence was annotated using the GenDB 2.4 annotation tool (13). The genome consists of a single circular chromosome of 6,475,296 bp, with an average G+C content of 41.88%. It contains five rRNA operons, 68 tRNA genes, and 4,959 coding genes.

Accession number(s).

The genome sequence has been deposited at the European Nucleotide Archive under the accession number LT622246.
  13 in total

1.  The Staden package, 1998.

Authors:  R Staden; K F Beal; J K Bonfield
Journal:  Methods Mol Biol       Date:  2000

2.  Analysis of cepA and other Bacteroides fragilis genes reveals a unique promoter structure.

Authors:  D P Bayley; E R Rocha; C J Smith
Journal:  FEMS Microbiol Lett       Date:  2000-12-01       Impact factor: 2.742

3.  GenDB--an open source genome annotation system for prokaryote genomes.

Authors:  Folker Meyer; Alexander Goesmann; Alice C McHardy; Daniela Bartels; Thomas Bekel; Jörn Clausen; Jörn Kalinowski; Burkhard Linke; Oliver Rupp; Robert Giegerich; Alfred Pühler
Journal:  Nucleic Acids Res       Date:  2003-04-15       Impact factor: 16.971

Review 4.  Bacterial evolution.

Authors:  C R Woese
Journal:  Microbiol Rev       Date:  1987-06

Review 5.  The indigenous gastrointestinal microflora.

Authors:  R D Berg
Journal:  Trends Microbiol       Date:  1996-11       Impact factor: 17.079

6.  Dominant and diet-responsive groups of bacteria within the human colonic microbiota.

Authors:  Alan W Walker; Jennifer Ince; Sylvia H Duncan; Lucy M Webster; Grietje Holtrop; Xiaolei Ze; David Brown; Mark D Stares; Paul Scott; Aurore Bergerat; Petra Louis; Freda McIntosh; Alexandra M Johnstone; Gerald E Lobley; Julian Parkhill; Harry J Flint
Journal:  ISME J       Date:  2010-08-05       Impact factor: 10.302

7.  The long-term stability of the human gut microbiota.

Authors:  Jeremiah J Faith; Janaki L Guruge; Mark Charbonneau; Sathish Subramanian; Henning Seedorf; Andrew L Goodman; Jose C Clemente; Rob Knight; Andrew C Heath; Rudolph L Leibel; Michael Rosenbaum; Jeffrey I Gordon
Journal:  Science       Date:  2013-07-05       Impact factor: 47.728

8.  Towards the human intestinal microbiota phylogenetic core.

Authors:  Julien Tap; Stanislas Mondot; Florence Levenez; Eric Pelletier; Christophe Caron; Jean-Pierre Furet; Edgardo Ugarte; Rafael Muñoz-Tamayo; Denis L E Paslier; Renaud Nalin; Joel Dore; Marion Leclerc
Journal:  Environ Microbiol       Date:  2009-07-06       Impact factor: 5.491

9.  Xylan-regulated delivery of human keratinocyte growth factor-2 to the inflamed colon by the human anaerobic commensal bacterium Bacteroides ovatus.

Authors:  Zaed Z R Hamady; Nigel Scott; Mark D Farrar; J Peter A Lodge; Keith T Holland; Terence Whitehead; Simon R Carding
Journal:  Gut       Date:  2009-09-07       Impact factor: 23.059

10.  Defining the bacteroides ribosomal binding site.

Authors:  Udo Wegmann; Nikki Horn; Simon R Carding
Journal:  Appl Environ Microbiol       Date:  2013-01-18       Impact factor: 4.792

View more
  2 in total

1.  Use of genetically modified bacteria for drug delivery in humans: Revisiting the safety aspect.

Authors:  Udo Wegmann; Ana Lucia Carvalho; Martin Stocks; Simon R Carding
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

2.  Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.

Authors:  Lars J Lindstad; Galiana Lo; Shaun Leivers; Zijia Lu; Leszek Michalak; Gabriel V Pereira; Åsmund K Røhr; Eric C Martens; Lauren S McKee; Petra Louis; Sylvia H Duncan; Bjørge Westereng; Phillip B Pope; Sabina Leanti La Rosa
Journal:  mBio       Date:  2021-06-01       Impact factor: 7.867

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.